Page last updated: 2024-12-05

piperonylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Piperonylic acid, also known as 3,4-methylenedioxybenzoic acid, is a naturally occurring compound found in various plants, including black pepper, nutmeg, and sassafras. It is a white crystalline solid with a slightly pungent odor. Piperonylic acid has been studied for its various pharmacological properties, including its potential as an antioxidant, antimicrobial, and anti-inflammatory agent. It has also been investigated for its role in plant defense mechanisms. The synthesis of piperonylic acid typically involves the oxidation of piperonal, which can be obtained from natural sources or synthesized chemically. Piperonylic acid is also a precursor to other important compounds, such as safrole and isosafrole, which have both medicinal and recreational uses. Research into piperonylic acid and its derivatives continues to explore its potential applications in medicine, agriculture, and other fields.'

piperonylic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

piperonylic acid : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a carboxy group at position 5. It is a natural product isolated from several plant species. It is a selective mechanism-based inactivator of the trans-cinnamate 4-hydroxylase enzyme and exhibits antifungal and skin wound healing properties. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7196
CHEMBL ID573781
CHEBI ID107644
SCHEMBL ID142318
MeSH IDM0047012

Synonyms (87)

Synonym
BRD-K52148119-001-01-5
1,3-benzodioxole-5-carbonsäure
SDCCGMLS-0065919.P002
SDCCGMLS-0065919.P001
SPECTRUM_001164
nsc 10072
3,4-methylene dioxybenzoic acid
3,4-dioxymethylenebenzoic acid
ai3-05972
benzoic acid, 3,4-(methylenedioxy)-
einecs 202-342-8
5-benzodioxolecarboxylic acid
1,3-benzodioxole-5-carboxylic acid
3,4-(methylenedioxy)benzoic acid
94-53-1
nsc-10072
piperonylic acid
heliotropic acid
benzoic acid,4-(methylenedioxy)-
protocatechuic acid methylene ether
nsc10072
3,4-methylenedioxybenzoic acid
BSPBIO_002803
piperonylic acid, 99%
NCGC00095970-01
KBIO2_006780
KBIO2_004212
KBIO2_001644
KBIOGR_001723
KBIO3_002023
KBIOSS_001644
SPECTRUM4_001152
SPECTRUM3_001022
SPECTRUM500580
NCGC00095970-02
STK397540
CHEBI:107644
AC-11342
vdvjgiyxdvpqlp-uhfffaoysa-
inchi=1/c8h6o4/c9-8(10)5-1-2-6-7(3-5)12-4-11-6/h1-3h,4h2,(h,9,10)
benzo[1,3]dioxole-5-carboxylic acid
AKOS000113163
CHEMBL573781
P0459
2h-1,3-benzodioxole-5-carboxylic acid
BBL011979
0hn ,
benzo[d][1,3]dioxole-5-carboxylic acid
unii-qx3v1no0kh
qx3v1no0kh ,
FT-0631477
AM20060211
AE-562/40258182
4DDK
piperonylic acid [inci]
piperonylic acid [mi]
bdbm153299
CCG-214272
SCHEMBL142318
3,4-methylenedioxy-benzoic acid
5-carboxy-1,3-benzodioxole
1,3-benzodioxole -5-carboxylic acid
benzo[d][i,3]dioxole-5-carboxylic acid
benzo[1,3]-dioxole-5-carboxylic acid
DTXSID6059104
W-100193
BS-3899
STR05605
mfcd00005830
Q27185967
F3318-0150
piperonylic acid, purum, >=97.0% (t)
CS-D1455
F16336
piperonylsaure
1,3-benzodioxole-5-carboxylic acid, 9ci
3,4-(methylenedioxy)-benzoic acid
3, 4-(methylenedioxy)benzoic acid
SY004612
HY-41404
BRD-K52148119-001-02-3
piperonylic acid-2,2-d2
PB47803
benzo[d][1,3]dioxole-5-carboxylicacid
EN300-20111
1,3-dioxaindane-5-carboxylic acid
Z104476884

Research Excerpts

Actions

ExcerptReferenceRelevance
"Piperonylic acid can inhibit the excessive proliferation of vascular smooth muscle cells and the lumen narrowing after injury of blood vessels, the mechanism of which is associated with the promoted gene expressions of cell cycle key regulators P21 and P27 (Tab. "( Inhibitory effects of piperonylic acid on the excessive proliferation of vascular smooth muscle cells and luminal stenosis.
Hong, T; Lin, L, 2014
)
2.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitorAny EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor that interferes with the action of trans-cinnamate 4-monooxygenase (EC 1.14.14.91).
vulneraryA drug used in treating and healing of wounds.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
benzodioxoles
monocarboxylic acidAn oxoacid containing a single carboxy group.
aromatic carboxylic acidAny carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency19.95260.011212.4002100.0000AID1030
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1090826Antifeedant activity against Hylobius abietis (pine weevil ) in compound pre-treated Scots pine twig at 50 mM measured after 24 hr by two-choice laboratory bioassay2007Journal of agricultural and food chemistry, Nov-14, Volume: 55, Issue:23
Quantitative structure-activity relationships of pine weevil antifeedants, a multivariate approach.
AID1884360Antagonist activity against human P2X5R stably transfected in human 1321N1 cells at 50 uM incubated for 30 mins by Fura-2 AM staining based calcium influx assay relative to control2022European journal of medicinal chemistry, Aug-05, Volume: 238Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors.
AID436559Inhibition of rat alpha-glucosidase assessed as p-nitrophenol release at 50 ug/ml2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
New furanoflavanoids, intestinal alpha-glucosidase inhibitory and free-radical (DPPH) scavenging, activity from antihyperglycemic root extract of Derris indica (Lam.).
AID667489Inhibition of recombinant type N-terminal His6-tagged 2 R67 DHFR expressed in Escherichia coli BL21 using DHF as substrate by spectrophotometry2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.
AID1884358Antagonist activity against human P2X4R stably transfected in human 1321N1 cells at 50 uM incubated for 30 mins by Fura-2 AM staining based calcium influx assay relative to control2022European journal of medicinal chemistry, Aug-05, Volume: 238Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors.
AID1884356Antagonist activity against human P2X2R stably transfected in human 1321N1 cells at 50 uM incubated for 30 mins by Fura-2 AM staining based calcium influx assay relative to control2022European journal of medicinal chemistry, Aug-05, Volume: 238Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors.
AID436561Antioxidant activity assessed as DPPH radical scavenging activity2009Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
New furanoflavanoids, intestinal alpha-glucosidase inhibitory and free-radical (DPPH) scavenging, activity from antihyperglycemic root extract of Derris indica (Lam.).
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Proceedings of the National Academy of Sciences of the United States of America, Aug-06, Volume: 110, Issue:32
Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (25.93)29.6817
2010's15 (55.56)24.3611
2020's5 (18.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.76 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]